Zobrazeno 1 - 10
of 164
pro vyhledávání: '"Mackie dS"'
Autor:
Ornstein MC, Rosenblatt LC, Yin X, Del Tejo V, Guttenplan SB, Ejzykowicz F, Beusterien K, Will O, Mackie DS, Skiles G, DeCongelio M
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 1729-1739 (2024)
Moshe C Ornstein,1 Lisa C Rosenblatt,2 Xin Yin,2 Viviana Del Tejo,2 Sarah B Guttenplan,2 Flavia Ejzykowicz,2 Kathleen Beusterien,3 Oliver Will,3 deMauri S Mackie,3 Grace Skiles,3 Marc DeCongelio3 1Taussig Cancer Institute, Cleveland Clinic, Cleveland
Externí odkaz:
https://doaj.org/article/4a0941cdab694181a95e35d32b1b515f
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 1517-1530 (2024)
Emuella Flood,1 Susan McCutcheon,2 Kathleen Beusterien,3 deMauri S Mackie,3 Stella Mokiou,1 Xavier Guillaume,3 Emily Mulvihill3 1Patient Centered Science, AstraZeneca, Gaithersburg, MD, USA; 2Global Medical Affairs, AstraZeneca, Cambridge, UK; 3Healt
Externí odkaz:
https://doaj.org/article/ab49d531bf594761824f298b401fa11d
Publikováno v:
Patient Preference and Adherence, Vol Volume 15, Pp 1515-1527 (2021)
Jinender Kumar,1 M Janelle Cambron-Mellott,2 Tom Tencer,1 Oliver Will,2 deMauri S Mackie,2 Kathleen Beusterien2 1Worldwide Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, NJ, USA; 2RWE Data and Analytics, Kantar Health, New Y
Externí odkaz:
https://doaj.org/article/93bb0eb071d945e59233db5a49b8e889
Autor:
Gudzune KA; Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland., Kaplan LM; The Obesity and Metabolism Institute, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts., Kahan S; National Center for Weight and Wellness, George Washington University School of Medicine, Washington, District of Columbia., Kumar RB; Comprehensive Weight Control Center, Weill Cornell Medical College, New York, New York., Dunn JP; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, Indiana., Ahmad NN; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, Indiana., Poon JL; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, Indiana., Sims TJ; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, Indiana., Mackie DS; Cerner Enviza, Real-World Evidence, North Kansas City, Missouri., Jauregui AK; Cerner Enviza, Real-World Evidence, North Kansas City, Missouri., Balkaran BL; Cerner Enviza, Real-World Evidence, North Kansas City, Missouri., Kan H; Value, Evidence, and Outcomes, Eli Lilly and Company, Indianapolis, Indiana. Electronic address: kan_hongjun@lilly.com., Ard J; Division of Public Health Sciences, Department of Epidemiology & Prevention, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2024 Oct; Vol. 30 (10), pp. 917-926. Date of Electronic Publication: 2024 Jun 18.
Autor:
Beusterien K; Real World Evidence, Oracle, Kansas City, MO, USA. kathleen.beusterien@oracle.com., Will O; Real World Evidence, Oracle, Kansas City, MO, USA., Flood E; Patient Centered Science, AstraZeneca, Gaithersburg, MD, USA., McCutcheon S; Global Medical Affairs, AstraZeneca, Cambridge, UK., Mackie DS; Real World Evidence, Oracle, Kansas City, MO, USA., Mokiou S; Global Medical Affairs, AstraZeneca, Cambridge, UK.
Publikováno v:
The patient [Patient] 2024 Jul; Vol. 17 (4), pp. 397-406. Date of Electronic Publication: 2024 Mar 15.
Autor:
Gupta S; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, USA., Costantino H; Cerner Enviza, an Oracle company, Kansas City, MO, USA., Ike C; EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA., Gupta S; Cerner Enviza, an Oracle company, Kansas City, MO, USA., Bhanegaonkar A; EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA., Su C; Cerner Enviza, an Oracle company, Kansas City, MO, USA., Thakkar S; Pfizer, New York, NY, USA., Mackie DS; Cerner Enviza, an Oracle company, Kansas City, MO, USA., Devgan G; Pfizer, New York, NY, USA., Katzenstein HM; EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA., Liu FX; EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA.
Publikováno v:
The oncologist [Oncologist] 2024 Mar 04; Vol. 29 (3), pp. 244-253.
Autor:
Kavelaars R; Twill Inc., 114 5th Ave., 10th Fl., New York, NY 10011, USA. Electronic address: ruthanne@twill.health., Ward H; NYU Langone Health, 550 1st Ave., New York, NY 10016, USA. Electronic address: hw2587@alum.barnard.edu., Mackie DS; Cerner Enviza, 2800 Rock Creek Pkwy, North Kansas City, MO 64117, USA. Electronic address: Demauri.Mackie@cernerenviza.com., Modi KM; Cerner Enviza, 2800 Rock Creek Pkwy, North Kansas City, MO 64117, USA. Electronic address: Kushal.Modi@cernerenviza.com., Mohandas A; Twill Inc., 114 5th Ave., 10th Fl., New York, NY 10011, USA. Electronic address: anita@twill.healt.
Publikováno v:
Journal of affective disorders [J Affect Disord] 2023 Sep 01; Vol. 336, pp. 81-91. Date of Electronic Publication: 2023 May 08.
Autor:
Aranishi T; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan., Ito T; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Fukuyama M; Department of Dermatology, Kyorin University Faculty of Medicine, Tokyo, Japan., Isaka Y; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan., Mackie DS; Cerner Enviza, Missouri, North Kansas City, USA., King-Concialdi K; Cerner Enviza, Missouri, North Kansas City, USA., Senglaub SS; Cerner Enviza, Missouri, North Kansas City, USA., Jaffe DH; Cerner Enviza, Missouri, North Kansas City, USA., Shimomura Y; Department of Dermatology, Yamaguchi University Graduate School of Medicine, Ube, Japan., Ohyama M; Department of Dermatology, Kyorin University Faculty of Medicine, Tokyo, Japan.
Publikováno v:
The Journal of dermatology [J Dermatol] 2023 Jan; Vol. 50 (1), pp. 26-36. Date of Electronic Publication: 2022 Nov 22.
Autor:
Jaffe DH; RWE, Cerner Enviza, Jerusalem, Israel., Gricar J; WWHEOR, Bristol-Myers Squibb, Princeton, New Jersey, USA., DeCongelio M; Research and Consulting, Cerner Enviza, New York, New York, USA., Mackie DS; RWE, Cerner Enviza, New York, New York, USA.
Publikováno v:
Thoracic cancer [Thorac Cancer] 2022 May; Vol. 13 (9), pp. 1240-1257. Date of Electronic Publication: 2022 Mar 30.
Publikováno v:
In Value in Health January 2022 25(1) Supplement:S248-S248